$0.65
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
ESLA: First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Overview
52-week range
$0.58
$3.15
2% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-5.9%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.05 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.05 | — | — | +16.7% | -7.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.13 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.15 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.06 | — | — | — | -3.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.09 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.11 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.01 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.78 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | $-2M | — | $-5M | $-6M | $-2M | — | $-3M |
| Net income | $-2M | $-2M | — | $-5M | $-6M | $-2M | — | $-3M |
| EPS (diluted) | $-0.05 | $-0.05 | — | $-0.13 | $-0.15 | $-0.06 | — | $-0.09 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $100,000 | — | — | $2M | $1M | $421,473 | $916,916 | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $2M | $2M | $2M | $2M | $1M | $944,268 | $2M | $2M |
| Total assets | $2M | $4M | $3M | $4M | $3M | $2M | $3M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $9M | $9M | $14M | $13M | $9M | $4M | $3M | $3M |
| Total equity | $-7M | $-5M | $-10M | $-10M | $-6M | $-2M | $143,731 | $746,286 |
Implied volatility — last 90 days
No IV snapshots yet for ESLA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.